C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survival
Increased fibroblast growth factor 23 (FGF23) is a risk factor for mortality, cardiovascular disease, and progression of chronic kidney disease. Limited data exist comparing the association of either c-terminal FGF23 (cFGF23) or intact FGF23 (iFGF23) in kidney transplant recipients (KTRs) with overa...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
08 April 2021
|
| In: |
BMC nephrology
Year: 2021, Volume: 22, Pages: 1-8 |
| ISSN: | 1471-2369 |
| DOI: | 10.1186/s12882-021-02329-7 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12882-021-02329-7 |
| Author Notes: | Chang Chu, Saban Elitok, Shufei Zeng, Yingquan Xiong, Carl-Friedrich Hocher, Ahmed A. Hasan, Bernhard K. Krämer and Berthold Hocher |
| Summary: | Increased fibroblast growth factor 23 (FGF23) is a risk factor for mortality, cardiovascular disease, and progression of chronic kidney disease. Limited data exist comparing the association of either c-terminal FGF23 (cFGF23) or intact FGF23 (iFGF23) in kidney transplant recipients (KTRs) with overall (all-cause) graft loss. |
|---|---|
| Item Description: | Gesehen am 12.07.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1471-2369 |
| DOI: | 10.1186/s12882-021-02329-7 |